X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (32539) 32539
Book Review (3306) 3306
Publication (1686) 1686
Newsletter (971) 971
Book Chapter (164) 164
Newspaper Article (150) 150
Conference Proceeding (72) 72
Dissertation (57) 57
Magazine Article (47) 47
Book / eBook (15) 15
Reference (9) 9
Trade Publication Article (8) 8
Government Document (7) 7
Transcript (6) 6
Web Resource (5) 5
Data Set (2) 2
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (27595) 27595
female (24822) 24822
animals (16211) 16211
progesterone (15442) 15442
humans (13802) 13802
pregnancy (8796) 8796
progesterone - blood (6755) 6755
rats (6168) 6168
adult (6089) 6089
progesterone - pharmacology (5601) 5601
male (4904) 4904
reproductive biology (4533) 4533
obstetrics & gynecology (4362) 4362
estrogen (4221) 4221
endocrinology & metabolism (3961) 3961
estradiol - pharmacology (3724) 3724
estradiol (3571) 3571
progesterone - administration & dosage (3543) 3543
estradiol - blood (3541) 3541
middle aged (3402) 3402
time factors (2938) 2938
abridged index medicus (2650) 2650
mice (2371) 2371
luteinizing hormone - blood (2338) 2338
women (2314) 2314
veterinary sciences (2243) 2243
research (2201) 2201
hormones (2197) 2197
neurosciences (2130) 2130
oncology (2107) 2107
receptors, progesterone - metabolism (1997) 1997
ovariectomy (1989) 1989
analysis (1982) 1982
dose-response relationship, drug (1959) 1959
cattle (1956) 1956
progesterone - metabolism (1930) 1930
agriculture, dairy & animal science (1911) 1911
breast cancer (1909) 1909
expression (1864) 1864
estradiol - administration & dosage (1753) 1753
aged (1719) 1719
ovulation (1695) 1695
rats, sprague-dawley (1520) 1520
pharmacology & pharmacy (1501) 1501
estrous-cycle (1479) 1479
follicle stimulating hormone - blood (1426) 1426
luteinizing-hormone (1395) 1395
health aspects (1385) 1385
postmenopausal women (1354) 1354
receptors, estrogen - metabolism (1354) 1354
physiological aspects (1333) 1333
cancer (1323) 1323
biochemistry & molecular biology (1259) 1259
estrus (1259) 1259
ovulation - drug effects (1254) 1254
immunohistochemistry (1240) 1240
breast neoplasms - drug therapy (1223) 1223
testosterone (1201) 1201
treatment outcome (1188) 1188
progesterone - therapeutic use (1155) 1155
breast neoplasms - pathology (1146) 1146
menopause (1145) 1145
cattle - physiology (1103) 1103
castration (1096) 1096
gene expression (1073) 1073
menstrual-cycle (1059) 1059
adolescent (1046) 1046
risk factors (1043) 1043
hormone replacement therapy (1024) 1024
uterus (1013) 1013
article (1012) 1012
uterus - drug effects (1011) 1011
brain (1010) 1010
gene-expression (1010) 1010
ovary - drug effects (998) 998
rats, wistar (982) 982
obstetrics and gynecology (971) 971
estrogens - pharmacology (963) 963
pregnancy rate (960) 960
medicine & public health (945) 945
cells, cultured (943) 943
cell biology (921) 921
prospective studies (917) 917
sheep (916) 916
rats, inbred strains (912) 912
breast neoplasms - metabolism (905) 905
care and treatment (895) 895
progesterone-receptor (891) 891
endometrium (884) 884
cells (880) 880
progesterone - physiology (874) 874
ovary - physiology (871) 871
endometrium - drug effects (870) 870
administration, oral (862) 862
estrogens (851) 851
physiology (850) 850
receptors, progesterone - analysis (846) 846
secretion (844) 844
fertility (836) 836
progesterone congeners - administration & dosage (833) 833
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (32517) 32517
German (287) 287
French (278) 278
Japanese (192) 192
Russian (136) 136
Italian (86) 86
Spanish (84) 84
Chinese (70) 70
Czech (49) 49
Portuguese (46) 46
Polish (38) 38
Bulgarian (22) 22
Korean (18) 18
Hungarian (17) 17
Dutch (14) 14
Turkish (14) 14
Danish (12) 12
Norwegian (11) 11
Slovak (11) 11
Finnish (10) 10
Swedish (10) 10
Persian (6) 6
Hebrew (3) 3
Romanian (3) 3
Croatian (2) 2
Serbian (2) 2
Ukrainian (2) 2
Afrikaans (1) 1
Arabic (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 12/2014, Volume 371, Issue 26, pp. 2457 - 2466
Journal Article
Circulation, ISSN 0009-7322, 02/2007, Volume 115, Issue 7, pp. 840 - 845
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 1/2008, Volume 100, Issue 2, pp. 121 - 133
Background Docetaxel is more effective than doxorubicin for patients with advanced breast cancer. The Breast International Group 02-98 randomized trial tested... 
CANCER PATIENTS | 1ST-LINE TREATMENT | PHASE-II TRIAL | THERAPY | EPIRUBICIN | ONCOLOGY | DOXORUBICIN PLUS CYCLOPHOSPHAMIDE | METHOTREXATE | COMBINATION CHEMOTHERAPY | FLUOROURACIL | CMF | Immunohistochemistry | Breast Neoplasms - surgery | Cyclophosphamide - administration & dosage | Adenocarcinoma - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Mastectomy - methods | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Receptors, Estrogen - analysis | Tamoxifen - administration & dosage | Receptors, Progesterone - analysis | Antineoplastic Agents, Phytogenic - administration & dosage | Breast Neoplasms - chemistry | Fluorouracil - administration & dosage | Adult | Female | Chemotherapy, Adjuvant | Odds Ratio | Adenocarcinoma - chemistry | Doxorubicin - administration & dosage | Drug Administration Schedule | Estrogen Receptor Modulators - administration & dosage | Kaplan-Meier Estimate | Treatment Outcome | Lymphatic Metastasis | Adenocarcinoma - drug therapy | Breast Neoplasms - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Disease-Free Survival | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Methotrexate - administration & dosage | Aged | Adenocarcinoma - surgery | Breast cancer | Dosage and administration | Drug therapy | Comparative analysis | Doxorubicin | Docetaxel | Clinical trials | Comparative studies | Chemotherapy | Index Medicus | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9707, pp. 2055 - 2063
Summary Background Tamoxifen is standard adjuvant treatment for postmenopausal women with hormone-receptor-positive breast cancer. We assessed the benefit of... 
Internal Medicine | CELLS | WOMEN | MEDICINE, GENERAL & INTERNAL | THERAPY | CYCLOPHOSPHAMIDE | METHOTREXATE | ANTAGONISM | CARCINOMA | FLUOROURACIL CHEMOTHERAPY | Cyclophosphamide - administration & dosage | Lymph Nodes - pathology | Humans | Middle Aged | Receptors, Estrogen - analysis | Antineoplastic Agents, Alkylating - administration & dosage | Tamoxifen - administration & dosage | Antimetabolites, Antineoplastic - administration & dosage | Receptors, Progesterone - analysis | Fluorouracil - administration & dosage | Postmenopause | Adult | Female | Chemotherapy, Adjuvant | Doxorubicin - administration & dosage | Antineoplastic Agents, Hormonal - administration & dosage | Lymphatic Metastasis | Adenocarcinoma - drug therapy | Breast Neoplasms - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - mortality | Aged | Adenocarcinoma - mortality | Adjuvant treatment | Breast cancer | Dosage and administration | Research | Drug therapy | Tamoxifen | Health aspects | Cancer | Heart failure | Chemotherapy | Womens health | Mortality | Clinical trials | Mammography | Radiation therapy | Cancer therapies | Tumors | Toxicity | Leukemia | Congestive heart failure | Doxorubicin | Subgroups | Rank tests | Randomization | Motivation | Registration | Mastectomy | Thromboembolism | Neutropenia | Review boards | Regression analysis | Patients | Survival | Post-menopause | Stomatitis | Cyclophosphamide | Anthracycline | Breast | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2009, Volume 27, Issue 33, pp. 5529 - 5537
Purpose TAnDEM is the first randomized phase III study to combine a hormonal agent and trastuzumab without chemotherapy as treatment for human epidermal growth... 
TRIAL | AROMATASE INHIBITOR | THERAPY | ONCOLOGY | SERUM HER-2/NEU | TAMOXIFEN | RESISTANCE | HER2 | COMBINATION | ESTROGEN-RECEPTOR | ENDOCRINE TREATMENT | Receptors, Estrogen - blood | Triazoles - administration & dosage | Triazoles - adverse effects | Confidence Intervals | Postmenopause - drug effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Breast Neoplasms - metabolism | Dose-Response Relationship, Drug | Nitriles - administration & dosage | Antibodies, Monoclonal, Humanized | Antineoplastic Agents, Hormonal - adverse effects | Neoplasm Metastasis | Adenocarcinoma - metabolism | Statistics, Nonparametric | Aged, 80 and over | Female | Drug Administration Schedule | Administration, Oral | Antineoplastic Agents, Hormonal - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Adenocarcinoma - drug therapy | Breast Neoplasms - drug therapy | Adenocarcinoma - secondary | Biomarkers, Tumor - blood | Disease-Free Survival | Maximum Tolerated Dose | Antibodies, Monoclonal - administration & dosage | Breast Neoplasms - pathology | Survival Analysis | Breast Neoplasms - mortality | Aged | Infusions, Intravenous | Nitriles - adverse effects | Receptors, Progesterone - blood | Receptor, ErbB-2 - blood | Trastuzumab | Adenocarcinoma - mortality | Index Medicus
Journal Article
American Journal of Pathology, The, ISSN 0002-9440, 2012, Volume 181, Issue 3, pp. 947 - 960
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2016, Volume 374, Issue 13, pp. 1221 - 1231
Journal Article
Tumori, ISSN 0300-8916, 01/2015, Volume 101, Issue 1, pp. 30 - 35
Background: Elderly patients with metastatic breast cancer (MBC) have more problems receiving chemotherapy than younger patients, especially with the presence... 
Metastatic breast cancer | FACT-B test | Metronomic therapy | Elderly patients | Vinorelbine | Quality of life | TRIAL | ONCOLOGY | CHEMOTHERAPY | Triazoles - administration & dosage | Estradiol - analogs & derivatives | Administration, Metronomic | Capecitabine | Humans | Receptors, Estrogen - analysis | Vinblastine - administration & dosage | Carcinoma, Ductal, Breast - chemistry | Nitriles - administration & dosage | Receptors, Progesterone - analysis | Antineoplastic Agents, Phytogenic - administration & dosage | Breast Neoplasms - chemistry | Carcinoma, Ductal, Breast - drug therapy | Anthracyclines - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Neoplasm Grading | Vinblastine - analogs & derivatives | Vinblastine - adverse effects | Aged, 80 and over | Carcinoma, Ductal, Breast - pathology | Female | Quinazolines - administration & dosage | Antineoplastic Agents, Phytogenic - adverse effects | Fluorouracil - analogs & derivatives | Administration, Oral | Biomarkers, Tumor - analysis | Deoxycytidine - administration & dosage | Estradiol - administration & dosage | Treatment Outcome | Breast Neoplasms - drug therapy | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Aged | Carcinoma, Lobular - drug therapy | Receptor, ErbB-2 - analysis | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Trastuzumab
Journal Article